Europe Near Infrared Imaging Market Size, Share & Industry Trends Analysis Report By Application, By Product (Reagents and Devices), By Reagents Type (Indocyanine Green (ICG)), By Devices Type, By End-user, By Country and Growth Forecast, 2022 - 2028
The Europe Near Infrared Imaging Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028).
For various applications in diagnosis (such as the mapping of tissue during surgery) and functional imaging of enzyme activity or distribution of oxygen in tissue, imaging systems that integrate two modalities on a single carrier are appealing. Unlike the far more constrained penetration depth of regular fluorescent labeling, NIR emission is placed in the tissue window, enabling optical imaging system up to tissue thicknesses of 1-3 cm.
Compared to magnetic resonance imaging (MRI), activation of NIR dyes is additionally more realistically feasible during surgery, indicating that such systems can be useful for highlighting tissue that needs to be removed during surgery. Since its introduction, the conventional first near-infrared (NIR-I) frame (NIR-I, spectrum from 700 to 900 nm) imaging approach has been widely used in clinical diagnosis, therapy, and academic research.
The second NIR frame optical imaging (NIR-II, spectrum from 1000 to 1700 nm) technique is superior to NIR-I in that it has a significant Stokes shift, minimal autofluorescence, a strong signal ratio, deep tissue penetration, and great tissue penetration depth. This technology has recently received a lot of interest and is now a popular field for biomedical research.
Endoscopic operations are performed on millions of people each year throughout Europe. Endoscopy is a critical inquiry in the diagnosis and therapy of gastrointestinal pathology. A high-quality endoscopy results in higher patient satisfaction and health outcomes. The European Association Brain and Congenital Heart Disease (ABC) Consortium is a multicenter, multidisciplinary organization that receives funding from the European Society for Paediatric Research.
The Germany market dominated the Europe Near Infrared Imaging Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $157.9 million by 2028.The UK market is anticipated to grow at a CAGR of 3.1% during (2022 - 2028). Additionally, The France market would experience a CAGR of 4.7% during (2022 - 2028).
Based on Application, the market is segmented into Preclinical Imaging, Cancer Surgeries, Gastrointestinal Surgeries, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries and Others. Based on Product, the market is segmented into Reagents and Devices. Based on Reagents Type, the market is segmented into Indocyanine Green (ICG) and Others. Based on Devices Type, the market is segmented into Near-infrared Fluorescence Imaging Systems and Near-infrared Fluorescence & Bioluminescence Imaging Systems. Based on End-user, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Research Laboratories. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Olympus Corporation, Hamamatsu Photonics K.K., Carl Zeiss Meditec AG (Carl Zeiss AG), PerkinElmer, Inc., Leica Microsystems GmbH (Danaher Corporation), Shimadzu Corporation, Karl Storz SE & Co. KG, and Fluoptics SAS.
Scope of the Study
Market Segments covered in the Report:
By Application
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook